Ovarian cancer and the immune system - The role of targeted therapies.

@article{Turner2016OvarianCA,
  title={Ovarian cancer and the immune system - The role of targeted therapies.},
  author={Taylor B Turner and Donald J Buchsbaum and John Michael Straughn and Troy D. Randall and Rebecca C. Arend},
  journal={Gynecologic oncology},
  year={2016},
  volume={142 2},
  pages={349-56}
}
The majority of patients with epithelial ovarian cancer are diagnosed with advanced disease. While many of these patients will respond initially to chemotherapy, the majority will relapse and die of their disease. Targeted therapies that block or activate specific intracellular signaling pathways have been disappointing. In the past 15years, the role of the immune system in ovarian cancer has been investigated. Patients with a more robust immune response, as documented by the presence of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Ovarian cancer and the immune system

Gynecologic oncology reports • 2017
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…